On November 22nd,the 2024 ChiPu Seed List TOP10 and Future Stars list of the Chinese Health Industry"ChiPu Award"were officially announced.Shanghai KEENSEA Medical Technology Co.,Ltd.(02225.HK)was honored on the"2024 Medical Device Innovation ChiPu Seed List TOP10"with its project"4K Naked-Eye 3D Fluorescence Intelligent Navigation Endoscope System."

On November 22nd,the Chinese Health Industry"ChiPu Award"officially announced the 2024 ChiPu Seed List TOP10 and the list of Future Stars.Shanghai KEENSEA Medical Technology Co.,Ltd.(02225)was honored on the"2024 Medical Device Innovation ChiPu Seed List TOP10"with its project"4K Naked-Eye 3D Fluorescence Intelligent Navigation Endoscope System."

In recent years,KEENSEA Medical Technology has been deeply involved in the research and development of endoscopy technology,achieving several significant breakthroughs.These cover a range of innovative products,from 4K ultra-high-definition endoscopy systems,3D and naked-eye 3D image processing systems,to 4K fluorescence and future multi-spectrum ultra-high-definition endoscopy systems.Notably,the company's Endo Next series True 4K 3D 4MOS ultra-high-definition fluorescence endoscopy system,launched in July 2023,integrates the three core technologies of"4K+3D+fluorescence"into one system,providing a more precise and efficient solution for minimally invasive surgery.The honor of being selected for the"ChiPu Seed List TOP10"is not only a high recognition of KEENSEA Medical's technological innovation capabilities but also a testament to its key role in driving industry transformation.